Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression
B Guo, M Zhang, W Hao, Y Wang, T Zhang… - Translational …, 2023 - nature.com
Mood disorders are associated with elevated inflammation, and the reduction of symptoms
after multiple treatments is often accompanied by pro-inflammation restoration. A variety of …
after multiple treatments is often accompanied by pro-inflammation restoration. A variety of …
Stress, epigenetics and depression: a systematic review
Environmental stressors, such as childhood maltreatment, have been recognized to
contribute to the development of depression. Growing evidence suggests that epigenetic …
contribute to the development of depression. Growing evidence suggests that epigenetic …
The impact of stress and major depressive disorder on hippocampal and medial prefrontal cortex morphology
EL Belleau, MT Treadway, DA Pizzagalli - Biological psychiatry, 2019 - Elsevier
Volumetric reductions in the hippocampus and medial prefrontal cortex (mPFC) are among
the most well-documented neural abnormalities in major depressive disorder (MDD) …
the most well-documented neural abnormalities in major depressive disorder (MDD) …
[HTML][HTML] The chronic mild stress (CMS) model of depression: History, evaluation and usage
P Willner - Neurobiology of stress, 2017 - Elsevier
Now 30 years old, the chronic mild stress (CMS) model of depression has been used in>
1300 published studies, with a year-on-year increase rising to> 200 papers in 2015. Data …
1300 published studies, with a year-on-year increase rising to> 200 papers in 2015. Data …
Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness
MA Calcia, DR Bonsall, PS Bloomfield, S Selvaraj… - …, 2016 - Springer
Rationale Psychosocial stressors are a well-documented risk factor for mental illness.
Neuroinflammation, in particular elevated microglial activity, has been proposed to mediate …
Neuroinflammation, in particular elevated microglial activity, has been proposed to mediate …
The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders
Psychiatric disorders, including major depressive disorder (MDD), bipolar disorder (BD) and
schizophrenia, affect a significant percentage of the world population. These disorders are …
schizophrenia, affect a significant percentage of the world population. These disorders are …
Making sense of rodent models of anhedonia
S Scheggi, MG De Montis… - International Journal of …, 2018 - academic.oup.com
A markedly reduced interest or pleasure in activities previously considered pleasurable is a
main symptom in mood disorder and psychosis and is often present in other psychiatric …
main symptom in mood disorder and psychosis and is often present in other psychiatric …
Chronic mild stress paradigm as a rat model of depression: facts, artifacts, and future perspectives
Rationale The chronic mild stress (CMS) paradigm was first described almost 40 years ago
and has become a widely used model in the search for antidepressant drugs for major …
and has become a widely used model in the search for antidepressant drugs for major …
Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats
Y Pan, XY Chen, QY Zhang, LD Kong - Brain, behavior, and immunity, 2014 - Elsevier
Depression is an inflammatory disorder. Pro-inflammatory cytokine interleukin-1 beta (IL-1β)
may play a pivotal role in the central nervous system (CNS) inflammation of depression …
may play a pivotal role in the central nervous system (CNS) inflammation of depression …
[HTML][HTML] Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-β levels in male mice
HM Savignac, Y Couch, M Stratford… - Brain, behavior, and …, 2016 - Elsevier
The manipulation of the enteric microbiota with specific prebiotics and probiotics, has been
shown to reduce the host's inflammatory response, alter brain chemistry, and modulate …
shown to reduce the host's inflammatory response, alter brain chemistry, and modulate …